| There are more and more old people in China nowadays, for our people's life expectancy increases gradually. With the increase of the request of living quality the demand of medical service increases too. That's why China's medicine market is getting bigger and bigger. But China's pharmaceutical company management is inefficient and with low scientific skills and low profits too. After China entering into the WTO, there will be a lot of multinational pharmaceutical company entering into our drugs market. They have strong economic power,advanced scientific skills and high efficiency of management. How to face their fierce competition is a good question to answer? Our pharmaceutical company can only use Merger&Acquisition ways to face the challenge! With the development of China's tax system, the tax burden now is becoming more and more important in pharmaceutical company's M&A. That's why tax planning becomes a very important part of pharmaceutical company's M&A. This thesis intents to help pharmaceutical company to use tax planning to arrange the M&A and financing activities. And the thesis aims to help pharmaceutical company to upgrade the idea of paying taxes, make M&A more scientific and systematical, then pharmaceutical company can choose the best and lowest ways in M&A and can make a lot of profits. The methods of economic analysis is essential to the thesis. This thesis hopes to analyze the tax paying in pharmaceutical company's M&A. It is divided into three parts: pharmaceutical company's M&A method and motivation; Analysis the tax paying in pharmaceutical company's M&A; the case of tax paying in pharmaceutical company's M&A. And put the point of the latter into two parts. Mainly with the pharmaceutical company's M&A and tax planning in this area. The main methods in this thesis are as follows: 1. Standard analysis and case analysis are combined together, the former pays attention to the value of economic behavior and qualitative analysis; the latter pays attention to describe the economic courses objectively and qualitative quantitative analysis. This thesis will combine two ways together and pay attention to the latter one in research. 2. Analysis of comparison: tax planning in enterprise M&A has distinction and generalization. Applying comparative analytical way contribute to disclose the essence and inherent operating mechanism of the tax planning in company M&A, and it will contribute to forming the theory and guide practice in pharmaceutical company's M&A. 3. Systematical analysis: from the point of systematical ways, the tax planning of pharmaceutical company's M&A is a system belong to company financing system, it will decided by multi-factors in company's M&A and relate to the external environment of the company and laws. Thus we can choose and make the optimum tax planning in pharmaceutical company's M&A and then can protect and keep the profit of the company. The main body of the thesis is divided into three chapters: Chapter One is about pharmaceutical company's M&A method and motivation. Firstly, it defines the concept of company's M&A. Secondly, it analyzes the specialty of pharmaceutical industry and the background of pharmaceutical industry of China; Finally it analyzes the motivation in the pharmaceutical company's M&A. Chapter Two is about the analysis of pharmaceutical company's M&A. Firstly, to introduce China's law and policy in company's M&A, for example the policy of company's M&A in tax paying problem etc. Secondly, to analyze the relation between tax planning and pharmaceutical company's M&A; then analysis the possibility of tax planning and pharmaceutical company's M&A; finally it will introduce the clues and methods in pharmaceutical company's M&A.Chapter Three is about the case study in pharmaceutical company's M&A. From the case of TaiJi Group M&A with XiNan pharmaceutical company and MeiDaKang Group merger with JiaLe pharmaceutical company, the thesis analyzes the importance of tax planning in M&A. The innovation of the thesis: 1. The... |
PDF Full Text Request